Molecularly Defined Antibody Conjugation through a Selenocysteine Interface-Reference-Cited by-同舟云学术

Molecularly Defined Antibody Conjugation through a Selenocysteine Interface

Published:2009-11-17 Issue:50 Volume:48 Page:12047-12057
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Hofer Thomas¹,Skeffington Lauren R.¹,Chapman Colby M.¹,Rader Christoph¹

Affiliation:

1. Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi901744t

Reference44 articles.

1. Global antibody development trends

2. Upping the ante on antibodies

3. Monoclonal antibody successes in the clinic

4. An engineered selenocysteine defines a unique class of antibody derivatives

5. Integrin αvβ3‐targeted therapy for Kaposi's sarcoma with an in vitro‐evolved antibody

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity;ChemMedChem;2024-07-02

2. Synthesis of site‐specific Fab‐drug conjugates using ADP‐ribosyl cyclases;Protein Science;2024-03-19

3. Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions;Archives of Pharmacal Research;2023-12-28

4. Introduction of Carbonyl Groups into Antibodies;Molecules;2023-12-01

5. The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules;Molecular Pharmaceutics;2023-01-25